Literature DB >> 2991770

Eukaryotic topoisomerases come into the limelight.

G North.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 2991770     DOI: 10.1038/316394a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Effects of histone acetylation on chromatin topology in vivo.

Authors:  L C Lutter; L Judis; R F Paretti
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  Enhancer-activated plasmid transcription complexes contain constrained supercoiling.

Authors:  P J Bonilla; S O Freytag; L C Lutter
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

Review 3.  The nuclear skeleton and the spatial arrangement of chromosomes in the interphase nucleus of vertebrate somatic cells.

Authors:  J Hubert; C A Bourgeois
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

4.  Topical treatment of psoriasis with the topoisomerase inhibitors novobiocin and nalidixic acid: a pilot study.

Authors:  V A Bohr; E A Abel; E M Farber; P C Hanawalt
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.

Authors:  P Hussy; G Maass; B Tümmler; F Grosse; U Schomburg
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

6.  Preferential DNA repair of an active gene in human cells.

Authors:  I Mellon; V A Bohr; C A Smith; P C Hanawalt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells.

Authors:  S P Singh; R Mohamed; C Salmond; M F Lavin
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

8.  DNA topoisomerase II cleaves at specific sites in the 5' flanking region of c-fos proto-oncogenes in vitro.

Authors:  M K Darby; R E Herrera; H P Vosberg; A Nordheim
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.